HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
If you or a loved one have recently been diagnosed with a form of cancer, the experts at Regional Cancer Care Associates of Freehold, NJ can help. Through comprehensive study of your particular cancer and medical history, with the application of the cutting-edge of medical technology, we create a treatment plan that most efficiently addresses your needs while keeping the complications of the process to a minimum. We also offer a range of additional services, from therapeutic counseling to financial advocacy. Even in the face of a cancer diagnosis, it is possible to live a good quality life, and we take pride in guiding you through the process.
Regional Cancer Care Associates also regularly conducts over 300 clinical trials in new and developing medical treatments. These trials are conducted with the utmost safety and consent of the subject in mind, and all expenses are covered by the company sponsor of the trial. Help increase the chance of improvement for cancer patients and their families and enroll today.
Our cancer treatment services include:
Make an appointment with Regional Cancer Care Associates of 326 Professional View Dr, Freehold, NJ 07728. You can get in touch with us through our online form.
You can get in touch with us through our online form.
"*" indicates required fields
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.